Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat
| Autor: | Sven-Ove Ögren, J. Lundström, M. Widman, L. B. Nilsson |
|---|---|
| Rok vydání: | 1993 |
| Předmět: |
Male
Quinpirole Metabolite Hypothermia Pharmacology Body Temperature Rats Sprague-Dawley chemistry.chemical_compound Dopamine receptor D2 Salicylamides medicine Remoxipride Haloperidol Animals Ergolines Chromatography High Pressure Liquid Biological Psychiatry Active metabolite Pergolide Effective dose (pharmacology) Rats Dopamine D2 Receptor Antagonists Psychiatry and Mental health Neurology chemistry Neurology (clinical) medicine.drug |
| Zdroj: | Journal of Neural Transmission. 93:187-203 |
| ISSN: | 1435-1463 0300-9564 |
| DOI: | 10.1007/bf01244996 |
| Popis: | Remoxipride and its active metabolites, the phenolic compounds FLA 797(−) and FLA 908(−) and the catecholic NCQ 436(−) and haloperidol, were examined for their ability to block hypothermia in the rat induced by dopamine (DA) D2 receptor stimulation. In addition, plasma levels of remoxipride and its active metabolites were measured using HPLC methods. Remoxipride (1 μmol/kg), given 30 or 15 min prior to, or 5 and 15 min after, the DA agonists, blocked the hypothermia induced by the DA D2 receptor agonists quinpirole (0.25mg/kg s.c.) and pergolide (0.1 mg/kg s.c). Administration of remoxipride by the i.v. or s.c. routes was more effective than by the i.p. route. FLA 797(−), FLA 908(−), and haloperidol were more effective than remoxipride in preventing the hypothermia caused by quinpirole, while NCQ 436(−) was less effective than remoxipride. The variation in time of remoxipride's action and effectiveness in blocking the induced hypothermia followed the variations in plasma concentrations. The plasma concentrations of the active metabolites were below the limit of determination ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink